AXN-2510

· Axion Bio, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXN-2510, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]